These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 32751111)

  • 1. Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis.
    Furue M
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-24 Negatively Regulates Keratinocyte Differentiation Induced by Tapinarof, an Aryl Hydrocarbon Receptor Modulator: Implication in the Treatment of Atopic Dermatitis.
    Vu YH; Hashimoto-Hachiya A; Takemura M; Yumine A; Mitamura Y; Nakahara T; Furue M; Tsuji G
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benvitimod upregulates filaggrin, involucrin and loricrin expressions via aryl hydrocarbon receptor-OVO-like 1 axis.
    Jia Q; Liu P; Wang X; Hu J; Jia J; Zhang J; Li H
    Arch Dermatol Res; 2024 Aug; 316(8):585. PubMed ID: 39207509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant soybean tar Glyteer rescues T-helper-mediated downregulation of filaggrin expression via aryl hydrocarbon receptor.
    Takei K; Mitoma C; Hashimoto-Hachiya A; Uchi H; Takahara M; Tsuji G; Kido-Nakahara M; Nakahara T; Furue M
    J Dermatol; 2015 Feb; 42(2):171-80. PubMed ID: 25482884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis.
    van den Bogaard EH; Bergboer JG; Vonk-Bergers M; van Vlijmen-Willems IM; Hato SV; van der Valk PG; Schröder JM; Joosten I; Zeeuwen PL; Schalkwijk J
    J Clin Invest; 2013 Feb; 123(2):917-27. PubMed ID: 23348739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diosmin restores the skin barrier by targeting the aryl hydrocarbon receptor in atopic dermatitis.
    Lee J; Song KM; Jung CH
    Phytomedicine; 2021 Jan; 81():153418. PubMed ID: 33302042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling.
    Amano W; Nakajima S; Kunugi H; Numata Y; Kitoh A; Egawa G; Dainichi T; Honda T; Otsuka A; Kimoto Y; Yamamoto Y; Tanimoto A; Matsushita M; Miyachi Y; Kabashima K
    J Allergy Clin Immunol; 2015 Sep; 136(3):667-677.e7. PubMed ID: 26115905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis.
    Tsuji G; Hashimoto-Hachiya A; Kiyomatsu-Oda M; Takemura M; Ohno F; Ito T; Morino-Koga S; Mitoma C; Nakahara T; Uchi H; Furue M
    Cell Death Dis; 2017 Jul; 8(7):e2931. PubMed ID: 28703805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of FLG, LOR, and IVL Expression by
    Hashimoto-Hachiya A; Tsuji G; Murai M; Yan X; Furue M
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29866992
    [No Abstract]   [Full Text] [Related]  

  • 10. Antioxidant Artemisia princeps Extract Enhances the Expression of Filaggrin and Loricrin via the AHR/OVOL1 Pathway.
    Hirano A; Goto M; Mitsui T; Hashimoto-Hachiya A; Tsuji G; Furue M
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28892018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis.
    Furue M; Hashimoto-Hachiya A; Tsuji G
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31683543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6.
    Kim BE; Leung DY; Boguniewicz M; Howell MD
    Clin Immunol; 2008 Mar; 126(3):332-7. PubMed ID: 18166499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin blocks the IL-13-induced deficiency of Epidermal Barrier Related Proteins via upregulation of miR-143 in HaCaT Keratinocytes.
    Jia QN; Zeng YP
    Int J Med Sci; 2020; 17(14):2087-2094. PubMed ID: 32922169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Cutaneous Microbiota in Atopic Dermatitis by Coal Tar via AHR-Dependent Induction of Antimicrobial Peptides.
    Smits JPH; Ederveen THA; Rikken G; van den Brink NJM; van Vlijmen-Willems IMJJ; Boekhorst J; Kamsteeg M; Schalkwijk J; van Hijum SAFT; Zeeuwen PLJM; van den Bogaard EH
    J Invest Dermatol; 2020 Feb; 140(2):415-424.e10. PubMed ID: 31344386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor-modulating agent.
    Bissonnette R; Stein Gold L; Rubenstein DS; Tallman AM; Armstrong A
    J Am Acad Dermatol; 2021 Apr; 84(4):1059-1067. PubMed ID: 33157177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Skin Barrier Function via Competition between AHR Axis versus IL-13/IL-4‒JAK‒STAT6/STAT3 Axis: Pathogenic and Therapeutic Implications in Atopic Dermatitis.
    Furue M
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33233866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidative Phytochemicals Accelerate Epidermal Terminal Differentiation via the AHR-OVOL1 Pathway: Implications for Atopic Dermatitis.
    Furue M; Hashimoto-Hachiya A; Tsuji G
    Acta Derm Venereol; 2018 Nov; 98(10):918-923. PubMed ID: 29972223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin.
    Pellerin L; Henry J; Hsu CY; Balica S; Jean-Decoster C; Méchin MC; Hansmann B; Rodriguez E; Weindinger S; Schmitt AM; Serre G; Paul C; Simon M
    J Allergy Clin Immunol; 2013 Apr; 131(4):1094-102. PubMed ID: 23403047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Therapeutic Skin Microbiomes Suppressing
    Lee E; Min K; Ahn H; Jeon BN; Park S; Yun C; Jeon H; Yeon JS; Kim H; Park H
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aryl hydrocarbon receptor/nuclear factor E2-related factor 2 (AHR/NRF2) signalling: A novel therapeutic target for atopic dermatitis.
    Hwang J; Newton EM; Hsiao J; Shi VY
    Exp Dermatol; 2022 Apr; 31(4):485-497. PubMed ID: 35174548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.